BCRX BioCryst Pharmaceuticals Inc

USD 5.27 0.82 18.426966
Icon

BioCryst Pharmaceuticals Inc (BCRX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 5.27

+0.82 (+18.43)%

USD 0.86B

8.90M

USD 11.33(+115.05%)

USD 18.00 (+241.56%)

Icon

BCRX

BioCryst Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 5.27
0.00 0
Take a Tour

BioCryst Pharmaceuticals Inc (BCRX) Stock Forecast

Show ratings and price targets of :
USD 11.33
(+115.05%)

Based on the BioCryst Pharmaceuticals Inc stock forecast from 2 analysts, the average analyst target price for BioCryst Pharmaceuticals Inc is USD 11.33 over the next 12 months. BioCryst Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of BioCryst Pharmaceuticals Inc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, BioCryst Pharmaceuticals Inc’s stock price was USD 5.27. BioCryst Pharmaceuticals Inc’s stock price has changed by +23.42% over the past week, +14.57% over the past month and -38.43% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...